BPH Global（USZ0）株式概要BPHグローバル・リミテッドは子会社とともに、オーストラリア、シンガポール、中国、東南アジアで伝統医薬品の調達、製造、マーケティング、販売に従事している。 詳細USZ0 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6リスク分析マイナスの株主資本 過去1年間で株主の希薄化は大幅に進んだ 意味のある時価総額がありません ( €3M )意味のある収益がありません ( A$2M )すべてのリスクチェックを見るUSZ0 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.0005該当なし内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-35m5m2016201920222025202620282031Revenue AU$9.5kEarnings AU$1.7kAdvancedSet Fair ValueView all narrativesBPH Global Ltd 競合他社2investSymbol: XTRA:2INVMarket cap: €62.9mGenetic AnalysisSymbol: DB:8V8Market cap: €42.7mbioXXmedSymbol: DB:T5OMarket cap: €222.9kValiRxSymbol: AIM:VALMarket cap: UK£1.5m価格と性能株価の高値、安値、推移の概要BPH Global過去の株価現在の株価AU$0.000552週高値AU$0.000552週安値AU$0.0005ベータ0.521ヶ月の変化0%3ヶ月変化0%1年変化0%3年間の変化-80.00%5年間の変化-98.67%IPOからの変化-98.82%最新ニュースBoard Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listingお知らせ • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listingお知らせ • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.お知らせ • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing最新情報をもっと見るRecent updatesBoard Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listingお知らせ • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listingお知らせ • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.お知らせ • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Apr 28BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Dec 31BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Dec 17BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct ListingReported Earnings • Oct 03Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.016 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.016 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.98m (loss narrowed 49% from FY 2023).お知らせ • Oct 02BPH Global Ltd, Annual General Meeting, Nov 27, 2024BPH Global Ltd, Annual General Meeting, Nov 27, 2024.Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.018 loss in FY 2023)Full year 2024 results: AU$0.001 loss per share (improved from AU$0.018 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.60m (loss narrowed 63% from FY 2023).New Risk • Jul 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Negative equity (-AU$244k). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€476.1k market cap, or US$515.7k).お知らせ • Apr 11BPH Global Ltd. Announces Executive ChangesBPH Global Limited announced the appointment of Justyn Stedwell as Company Secretary. Justyn has over 17 years' experience as a Company Secretary of ASX listed companies and has also served as a Non-Executive Director on several ASX listed company Boards. He holds a Bachelor of Commerce from Monash University, a Graduate Diploma of Accounting from Deakin University and Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia. Further to this appointment, Belinda Cleminson and Shelby Coleman have resigned as joint CompanySecretaries.お知らせ • Jan 18BPH Global Ltd Announces Change of Joint Company SecretaryBPH Global Ltd. announced that Shelby Coleman has been appointed as Joint Company Secretary, effective immediately. Ms Coleman holds a Bachelor of Laws and a Bachelor of Arts from Victoria University of Wellington.She is experienced in ASX and ASIC compliance, providing advice on corporate governance and compliance issues as well as other regulatory maters. As a member of Automic Group's Company Secretary team, Ms Coleman assists a number of ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Elizabeth Spooner will step down as Joint Company Secretary effecve immediately. Ms Belinda Cleminson of Automic Group will continue in her role, being Joint Company Secretary.New Risk • Dec 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m (AU$339 revenue, or US$231). Market cap is less than US$10m (€1.59m market cap, or US$1.75m).お知らせ • Dec 12BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company’s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought.BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023.お知らせ • Oct 20BPH Global Ltd, Annual General Meeting, Nov 21, 2023BPH Global Ltd, Annual General Meeting, Nov 21, 2023, at 16:00 AUS Eastern Standard Time. Location: at Automic offices at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To consider the Adoption of Remuneration Report; To consider the Election of Yanhua Huang as Director; To consider the Re-election of Huan Qing Gu as Director; To consider the ASX Listing Rule 7.1A Approval of Future Issue of Securities; To consider the Ratification of Prior Issue of Placement Shares; To consider the Approval of Issue of Placement Options; To consider the Approval of Issue of Options to Sanlam Private Wealth Pty Ltd; To consider the Approval of Issue of Shares and Options on conversion of 368,750 Convertible Notes; To consider the Approval of Issue of Shares and Options to Mr Paul Stephenson, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Francesco Cannavo, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Matthew Leonard, Director of the Company; and to consider other matters if any.Reported Earnings • Oct 05Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.004 loss per share (improved from AU$0.005 loss in FY 2022). Net loss: AU$4.26m (loss narrowed 20% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.お知らせ • Sep 21BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023.Reported Earnings • Sep 01Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)Full year 2023 results: AU$0.003 loss per share. Net loss: AU$3.75m (loss widened 1.7% from FY 2022).New Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.7m free cash flow). Share price has been highly volatile over the past 3 months (259% average daily change). Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (€1.56m market cap, or US$1.69m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding).お知らせ • Jul 06BPH Global Ltd Appoints Michael Huang as Non-Executive DirectorThe Board of BPH Global Ltd. advised the appointment of Michael (Yanhua) Huang to the Board of Directors of the Company as a Non-Executive Director. Michael's return to the Board of BP8, marks a further consolidation of the Company' strategy to reinvigorate and further develop its bird's nest and dendrobium-infused bird's nest sales business in China (Bird's Nest Business). Michael Huang took the lead role on behalf of BP8 in conducting the pilot program in January and February this year. The pilot program trialled supply and distribution channels for the sale of bird's nest products via China Tobacco's outlets in Guangzhou and via social media influencers on Douyin, the China version of TikTok. Michael Huang brings his extensive experience and personal network in sales and marketing to the Board.お知らせ • May 12Stemcell United Limited Announces Board ChangesStemcell United Limited advised that Mr. Paul Rosen has tendered his resignation as a Non-Executive Director and Chairman, effective 12 May 2023.The Company announced the appointment of Mr. Paul Stephenson as independent non-executive Chair of the Board, effective immediately.Board Change • Apr 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Director Matthew Leonard was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.株主還元USZ0DE BiotechsDE 市場7D0%0.4%3.9%1Y0%-13.6%2.6%株主還元を見る業界別リターン: USZ0過去 1 年間で-13.6 % の収益を上げたGerman Biotechs業界を上回りました。リターン対市場: USZ0は、過去 1 年間で2.6 % のリターンを上げたGerman市場を下回りました。価格変動Is USZ0's price volatile compared to industry and market?USZ0 volatilityUSZ0 Average Weekly Movement0%Biotechs Industry Average Movement8.5%Market Average Movement6.1%10% most volatile stocks in DE Market12.9%10% least volatile stocks in DE Market2.7%安定した株価: データは利用できません。時間の経過による変動: 過去 1 年間のUSZ0のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1984n/aMatthew Leonardbphglobal.comBPHグローバル・リミテッドは子会社とともに、オーストラリア、シンガポール、中国、東南アジアで伝統医薬品の調達、生産、マーケティング、販売に従事している。同社の製品には、生の燕の巣、燕の巣加工品、Caulerpa Lentillifera、海ブドウ、海藻などがある。同社の製品は食品、栄養、ヘルスケア、健康サプリメント、化粧品、パーソナルケア産業で使用されている。前身はステムセル・ユナイテッド・リミテッドで、2023年6月にBPHグローバル・リミテッドに社名変更。BPHグローバル・リミテッドは1984年に設立され、本社はオーストラリアのメルボルンにある。もっと見るBPH Global Ltd 基礎のまとめBPH Global の収益と売上を時価総額と比較するとどうか。USZ0 基礎統計学時価総額€2.90m収益（TTM）-€1.33m売上高(TTM)€1.07m2.7xP/Sレシオ-2.2xPER（株価収益率USZ0 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計USZ0 損益計算書（TTM）収益AU$1.73m売上原価AU$1.76m売上総利益-AU$35.79kその他の費用AU$2.12m収益-AU$2.16m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.00092グロス・マージン-2.07%純利益率-124.84%有利子負債／自己資本比率-70.7%USZ0 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 17:03終値2026/05/25 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BPH Global Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.
お知らせ • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.
お知らせ • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Apr 28BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Dec 31BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Dec 17BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Reported Earnings • Oct 03Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.016 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.016 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.98m (loss narrowed 49% from FY 2023).
お知らせ • Oct 02BPH Global Ltd, Annual General Meeting, Nov 27, 2024BPH Global Ltd, Annual General Meeting, Nov 27, 2024.
Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.018 loss in FY 2023)Full year 2024 results: AU$0.001 loss per share (improved from AU$0.018 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.60m (loss narrowed 63% from FY 2023).
New Risk • Jul 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Negative equity (-AU$244k). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€476.1k market cap, or US$515.7k).
お知らせ • Apr 11BPH Global Ltd. Announces Executive ChangesBPH Global Limited announced the appointment of Justyn Stedwell as Company Secretary. Justyn has over 17 years' experience as a Company Secretary of ASX listed companies and has also served as a Non-Executive Director on several ASX listed company Boards. He holds a Bachelor of Commerce from Monash University, a Graduate Diploma of Accounting from Deakin University and Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia. Further to this appointment, Belinda Cleminson and Shelby Coleman have resigned as joint CompanySecretaries.
お知らせ • Jan 18BPH Global Ltd Announces Change of Joint Company SecretaryBPH Global Ltd. announced that Shelby Coleman has been appointed as Joint Company Secretary, effective immediately. Ms Coleman holds a Bachelor of Laws and a Bachelor of Arts from Victoria University of Wellington.She is experienced in ASX and ASIC compliance, providing advice on corporate governance and compliance issues as well as other regulatory maters. As a member of Automic Group's Company Secretary team, Ms Coleman assists a number of ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Elizabeth Spooner will step down as Joint Company Secretary effecve immediately. Ms Belinda Cleminson of Automic Group will continue in her role, being Joint Company Secretary.
New Risk • Dec 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m (AU$339 revenue, or US$231). Market cap is less than US$10m (€1.59m market cap, or US$1.75m).
お知らせ • Dec 12BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company’s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought.BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023.
お知らせ • Oct 20BPH Global Ltd, Annual General Meeting, Nov 21, 2023BPH Global Ltd, Annual General Meeting, Nov 21, 2023, at 16:00 AUS Eastern Standard Time. Location: at Automic offices at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To consider the Adoption of Remuneration Report; To consider the Election of Yanhua Huang as Director; To consider the Re-election of Huan Qing Gu as Director; To consider the ASX Listing Rule 7.1A Approval of Future Issue of Securities; To consider the Ratification of Prior Issue of Placement Shares; To consider the Approval of Issue of Placement Options; To consider the Approval of Issue of Options to Sanlam Private Wealth Pty Ltd; To consider the Approval of Issue of Shares and Options on conversion of 368,750 Convertible Notes; To consider the Approval of Issue of Shares and Options to Mr Paul Stephenson, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Francesco Cannavo, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Matthew Leonard, Director of the Company; and to consider other matters if any.
Reported Earnings • Oct 05Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.004 loss per share (improved from AU$0.005 loss in FY 2022). Net loss: AU$4.26m (loss narrowed 20% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
お知らせ • Sep 21BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023.
Reported Earnings • Sep 01Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)Full year 2023 results: AU$0.003 loss per share. Net loss: AU$3.75m (loss widened 1.7% from FY 2022).
New Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.7m free cash flow). Share price has been highly volatile over the past 3 months (259% average daily change). Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (€1.56m market cap, or US$1.69m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding).
お知らせ • Jul 06BPH Global Ltd Appoints Michael Huang as Non-Executive DirectorThe Board of BPH Global Ltd. advised the appointment of Michael (Yanhua) Huang to the Board of Directors of the Company as a Non-Executive Director. Michael's return to the Board of BP8, marks a further consolidation of the Company' strategy to reinvigorate and further develop its bird's nest and dendrobium-infused bird's nest sales business in China (Bird's Nest Business). Michael Huang took the lead role on behalf of BP8 in conducting the pilot program in January and February this year. The pilot program trialled supply and distribution channels for the sale of bird's nest products via China Tobacco's outlets in Guangzhou and via social media influencers on Douyin, the China version of TikTok. Michael Huang brings his extensive experience and personal network in sales and marketing to the Board.
お知らせ • May 12Stemcell United Limited Announces Board ChangesStemcell United Limited advised that Mr. Paul Rosen has tendered his resignation as a Non-Executive Director and Chairman, effective 12 May 2023.The Company announced the appointment of Mr. Paul Stephenson as independent non-executive Chair of the Board, effective immediately.
Board Change • Apr 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Director Matthew Leonard was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
